BHCM
TMO icon

Brevan Howard Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Brevan Howard Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.63M Buy
11,225
+10,489
+1,425% +$5.04M 0.04% 299
2026
Q1 		$362K Sell
736
-7,731
-91% -$4.2M ﹤0.01% 1494
2025
Q4 		$4.91M Buy
8,467
+3,590
+74% +$2.03M 0.05% 247
2025
Q3 		$2.37M Sell
4,877
-21,394
-81% -$9.96M 0.01% 487
2025
Q2 		$10.7M Buy
26,271
+24,495
+1,379% +$10.2M 0.06% 177
2025
Q1 		$884K Sell
1,776
-1,931
-52% -$1.05M 0.01% 544
2024
Q4 		$1.93M Sell
3,707
-2,300
-38% -$1.26M 0.01% 292
2024
Q3 		$3.72M Sell
6,007
-18,333
-75% -$10.9M 0.03% 160
2024
Q2 		$13.5M Buy
+24,340
New +$13.9M 0.12% 39

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brevan Howard Capital Management's TMO Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Thermo Fisher Scientific (TMO) stake by 1,425% in Q2 2026, buying an estimated $5.04M and bringing the position to 11,225 shares worth $5.63M. The position accounts for 0.04% of the portfolio, ranked #299.

Brevan Howard Capital Management first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. The position peaked at $13.5M in Q2 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Brevan Howard Capital Management held 11,225 shares of Thermo Fisher Scientific worth $5.63M as of Q2 2026.
  • Brevan Howard Capital Management bought 10,489 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.04M.
  • Thermo Fisher Scientific made up 0.04% of Brevan Howard Capital Management's portfolio in Q2 2026, its #299 holding.
  • Brevan Howard Capital Management first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Thermo Fisher Scientific position peaked at $13.5M in Q2 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.